Clinical and biological basis of lung cancer prevention Y. Martinet, F. R. Hirsch, N. Martinet, et al Basel, Switzerland: Birkhäuser Verlag, 1997, sFr 178/DM 208/öS 1519. ISBN 3-7643-5778-9 by Sörenson, S.
RESPIRATORY MEDICINE (1998) 92, 1373-1375 
Book Reviews 
[ MEDICINE ) 
Clinical and Biological Basis of Lung 
Cancer Prevention 
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Basel, Switzerland: Birkhauser Verlag, 1997, 
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While the results of lung cancer treatment have remained 
relatively stable at a low level for many years, a striking 
development has taken place in the understanding of the 
biological mechanisms which operate in the early stages of 
this disease. The International Association for the Study of 
Lung Cancer, IASLC, sponsored two workshops on lung 
cancer prevention in 1996 and the lectures delivered on 
these occasions are presented in this volume. There are 30 
contributions, mostly dealing with genetic and biological 
characteristics of early malignant events. 
The background for these workshops is evident: lung 
cancer is, on a global basis, a leading cause of death due to 
neoplastic disease. The battle against tobacco use has, at 
best, met with limited success and the smoking epidemic is 
rapidly spreading to developing countries. From a public 
health perspective, this scenario represents an enormous 
challenge. Individuals who stop smoking will experience a 
gratifying reduction of lung cancer risk but the process is 
slow and a heavy smoker may suffer from an increased risk 
for as long as 20-30 years after quitting. In this context, 
chemoprevention becomes a relevant consideration. 
Clinical studies of lung cancer prevention may require 
an excessively long time for completion if lung cancer 
incidence and mortality are used as endpoints. One of the 
potential applications of molecular biology and genetics 
is the introduction of intermediate markers such as gene 
mutations, oncogene activation or inactivation of tumour 
suppressor genes. Currently, a vast array of possible 
markers are available but their use needs to be validated. 
Harvesting of material for biological studies may be 
performed by sputum examination or bronchoscopy. Wide- 
spread application of bronchoscopy in the prophylactic 
setting may, however, be impractical, expensive and diffi- 
cult for the population at risk to accept. Fluorescence 
bronchoscopy has been proposed as a method for early 
identification of premalignant changes in the central 
bronchial tree by Stephen Lam and associates but other 
investigators have not been able to confirm the merits of 
this approach. 
Although early diagnosis and chemoprevention are 
intellectually appealing, the practical implications are 
largely unproven. There are also other limitations to the 
message of these workshops. Early diagnosis by radio- 
graphic screening was not a theme, and the reason is 
obvious. A radiographic diagnosis is a late event in the 
biological history of a tumour although it could sometimes 
be made earlier than in common clinical practice as a result 
of screening. As for histological types, squamous cell carci- 
noma is favoured by the type of diagnostic efforts outlined 
here. Both sputum cytology and bronchoscopy are much 
less efficient for sampling of material from peripheral parts 
of the lung, the most common site of adenocarcinoma. This 
tumour type has, in several countries, become the most 
frequent histological type of lung cancer. 
It is natural that the contents of a volume generated by 
two workshops is more akin to a smorgasbord than to a 
conventional textbook. However, the spectrum of presen- 
tations works very well as an introduction to an exciting 
field which may generate new approaches to the difficult 
problem of lung cancer. 
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One of a continuing series in Lung Biology in Health und 
Disease, Vol. 118 on Physiological Basis of Ventilutoly 
Supyovt has four parts: (1) Physiology underlying ventila- 
tory support, (2) consequences of mechanical ventilation, 
(3) implementing ventilatory support and (4) specific 
problems in ventilation, presented in a total of 38 chapters, 
The authors are well-known and respected researchers and 
clinicians, who with this volume have succeeded in produc- 
ing a comprehensive yet concise and very readable text. 
Extensive use of tables and figures serves the valuable 
function of summarizing large amounts of data in an 
understandable way to present a variety of physiological 
mechanisms. Even though the book represents a rapidly 
changing area of pulmonary research, the references are 
in-depth and up-to-date. 
The first four chapters focus on basic physiology, includ- 
ing control of breathing, loaded breathing and dyspnoea, 
respiratory fatigue and assessment of respiratory drive. The 
next four deal with respiratory mechanics, including the 
role of surfactant and work of breathing, followed by 
chapters on gas exchange, where the effects of different 
ventilatory strategies on various disease states such as 
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